Response: Co-occurrence of giant cell arteritis in patients with polymyalgia rheumatica. Reply letter to Castañeda and González-Gay (Letter to the Editor: Concurrent baseline diagnosis of giant cell arteritis and polymyalgia rheumatica - A systematic review and meta-analysis. Semin Arthritis Rheum. 2022;56:152069.)
- 18 December 2022
- journal article
- letter
- Published by Elsevier in Seminars in Arthritis and Rheumatism
- Vol. 58, 152155
Abstract
No abstract availableFunding Information
- Health Research Foundation of Central Denmark Region
This publication has 7 references indexed in Scilit:
- Concurrent baseline diagnosis of giant cell arteritis and polymyalgia rheumatica – A systematic review and meta-analysisSeminars in Arthritis and Rheumatism, 2022
- The Utility of 18F‐FDG PET/CT in Patients With Clinical Suspicion of Polymyalgia Rheumatica and Giant Cell Arteritis: A Prospective, Observational, and Cross‐sectional StudyACR Open Rheumatology, 2020
- Diagnostic accuracy of ultrasound for detecting large-vessel giant cell arteritis using FDG PET/CT as the referenceRheumatology, 2019
- Large-vessel giant cell arteritis: a cohort studyRheumatology, 2014
- Assessment of aortitis by semiquantitative analysis of 180-min 18F-FDG PET/CT acquisition imagesEuropean Journal of Nuclear Medicine and Molecular Imaging, 2014
- Incidence of temporal arteritis in patients with polymyalgia rheumatica: a prospective study using colour Doppler ultrasonography of the temporal arteriesRheumatology, 2002
- Epidemiology of biopsy proven giant cell arteritis in northwestern Spain: trend over an 18 year periodAnnals of the Rheumatic Diseases, 2001